Transcriptional pattern of TGF-beta1 inhibitory effect on mouse C2C12 myoblasts differentiation

Z Wicik1, T Sadkowski, M Jank

  • 1Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159, 02-776 Warsaw, Poland.

Insights

Transforming growth factor-beta1 (TGF-beta1) significantly inhibits muscle cell development in C2C12 myoblasts. This study identifies key genes and pathways affected by TGF-beta1 during myogenesis.

Area of Science:

  • Muscle biology
  • Cellular signaling
  • Molecular genetics

Background:

  • Transforming growth factor-beta1 (TGF-beta1) acts as a negative regulator of myogenesis, impacting muscle cell proliferation, differentiation, and function.
  • C2C12 myoblasts are a widely used model system for studying muscle cell differentiation.

Purpose of the Study:

  • To define the effect of TGF-beta1 on the myogenesis of C2C12 myoblasts.
  • To identify genes and pathways regulated by TGF-beta1 during C2C12 myoblast differentiation.

Main Methods:

  • Treatment of differentiating C2C12 mouse myoblasts with TGF-beta1.
  • Gene expression profiling to identify differentially expressed genes.
  • Pathway analysis to determine affected biological processes and molecular functions.

Main Results:

  • TGF-beta1 significantly inhibits C2C12 myoblast differentiation, evidenced by impaired cell fusion and reduced myosin heavy chain expression.
  • Gene expression analysis revealed 502 differentially expressed genes (436 down-regulated, 66 up-regulated) in response to TGF-beta1.
  • TGF-beta1 significantly impacted 29 biological processes, 29 molecular functions, and 59 pathways, with notable inhibition in cadherin and Wnt signaling pathways.
  • Key TGF-beta1 target genes, including Max, Creb1, Ccna2, and Bax, were identified.

Conclusions:

  • TGF-beta1 is a potent inhibitor of C2C12 myoblast differentiation.
  • TGF-beta1 exerts its inhibitory effects by modulating specific gene expression profiles and critical signaling pathways, including cadherin and Wnt.
  • Identification of key target genes provides insights into the molecular mechanisms underlying TGF-beta1-mediated inhibition of myogenesis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...